Lucille S. Markey Charitable Foundation, the Committee on Bridges to Independence, the Committee on Biomedical and Behavioral Personnel, and the Committee on Training Needs of Health Professionals in Domestic Violence. Dr. Pion received a Merit Award from the NIH in 1999 for her survey and evaluation work and is an associate member of the National Academy of Sciences. Dr. Pion obtained her Ph.D. from Claremont University in 1980 and completed a National Research Service Award (NRSA) postdoctoral traineeship in Northwestern University’s Evaluation and Research Methodology program.
Henry F. VanBrocklin is currently professor of radiology and biomedical imaging at the University of California San Francisco (UCSF) and director of radiopharmaceutical research in the Center for Functional and Molecular Imaging. His work in the field spans many disciplines from short-lived radioisotope production to the creation of fluorine-18 and carbon-11 labeling chemistry strategies for new radiotracer preparation and application. His current research interests include development of automated devices for the production of fluorine-18 labeled molecules, preparation of radiopharmaceutical probes for PET and SPECT blood flow measurement, design of imaging agents targeting cancer cell surface markers, and the application of imaging in drug development. He has on-going collaborations with several pharmaceutical companies. He has been very active within the SNM (Society of Nuclear Medicine) leadership as the president of the Radiopharmaceutical Sciences Council and recently as president of the Molecular Imaging Center of Excellence. He participated in the development and implementation of the SNM’s Molecular Imaging strategic five-year plan. He has been an advocate for the appropriate regulation of radiopharmaceuticals working on multiple task forces within the SNM and in workshops with the FDA. He led a task force to respond to the FDA regarding the exploratory IND (XIND) draft guidance and has subsequently successfully implemented XIND studies at UCSF using the final FDA guidance. Additionally, Dr. VanBrocklin has overseen the complete build out of a state-of-the-art radiochemistry, imaging, training and treatment facility at UCSF for basic R&D and preclinical studies as well as clinical applications.
John F. Wacker is a laboratory fellow at the Pacific Northwest National Laboratory (PNNL) in Richland, Washington. Dr. Wacker currently works on nuclear forensic analysis and related fields, as well as working on projects that improve and utilize various ultratrace analytical techniques. He supports both the U.S. and international Technical Nuclear Forensics communities as a lead technical expert on the laboratory analysis of nuclear and